Mansi L, Rambaldi P F, Marino G, Pecori B, Del Vecchio E
Institute of Radiological Sciences, Second University, Naples, Italy.
Clin Nucl Med. 1996 Sep;21(9):700-3. doi: 10.1097/00003072-199609000-00006.
The uptake of Tc-99m tetrofosmin (TF) is reported in a case of parathyroid adenoma. A 65-year-old woman was studied on different days with TF, Tc-99m sestamibi (MIBI) and Tl-201 chloride (Tl). TF and MIBI injections were preceded by oral administration of potassium perchlorate. Clear identification of the adenoma was observed in all scans. No further information was obtained using a subtraction technique with Tc-99m pertechnetate. Regarding the thyroid/parathyroid ratio, different kinetics between TF and MIBI appear to be demonstrated. In particular, thyroid washout was observed with MIBI but not with TF.
有一例甲状旁腺腺瘤患者的锝-99m替曲膦(TF)摄取情况被报道。一名65岁女性在不同日期分别接受了TF、锝-99m甲氧基异丁基异腈(MIBI)和氯化铊(Tl)检查。在注射TF和MIBI之前口服了高氯酸钾。在所有扫描中均清晰识别出腺瘤。使用锝-99m高锝酸盐的减影技术未获得更多信息。关于甲状腺/甲状旁腺比值,TF和MIBI之间似乎表现出不同的动力学。特别是,MIBI观察到甲状腺洗脱,而TF未观察到。